#1AN INTRODUCTION TO BEAUTYHEALTH MARCH 2022 ♡ BEAUTYHEALTH™#2DISCLAIMER This Presentation contains certain forward-looking statements. These statements may relate to, but are not limited to, expectations of future operating results or financial performance of The Beauty Health Company (the "Company"), the calculation of certain key financial and operating metrics, capital expenditures, the introduction of new products, expansion into new markets, projections of market opportunity and the ability to execute certain strategic initiatives. Some of the forward-looking statements can be identified by the use of forward-looking words such as "anticipate," "expect," "suggests," "plan," "believe," "intend," "estimates," "targets," "projects," "should," "could," "would," "may," "will," "forecast" and other similar expressions. These are intended to identify forward-looking statements. All forward-looking statements are based upon management estimates and forecasts and reflect the views, assumptions, expectations, and opinions of the Company as of the date of this Presentation, and may include, without limitation, changes in general economic conditions as a result of COVID-19, all of which are subject to change. Any such estimates, assumptions, expectations, forecasts, views or opinions set forth in this Presentation constitute the Company's judgments and should be regarded as indicative, preliminary and for illustrative purposes only. The forward-looking statements and projections contained in this Presentation are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause the Company's actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial condition. Although such forward-looking statements have been made in good faith and are based on assumptions we believe to be reasonable, there is no assurance that the expected results will be achieved. Many factors could adversely affect our business and financial performance. We discussed a number of material risks in our Prospectus filed pursuant to Rule 424(b)(5) of the Securities Act on July 26, 2021 and other filings with the Securities and Exchange Commission. Those risks continue to be relevant to our performance and financial condition. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time and it is not possible for management to predict all such risk factors, nor can it assess the impact of all such risk factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We expressly disclaim any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise. Description of Non-GAAP Financial Measures In addition to results determined in accordance with accounting principles generally accepted in the United States of America (GAAP), management utilizes certain non-GAAP financial measures such as adjusted gross margin, adjusted EBITDA, and adjusted EBITDA margin for purposes of evaluating ongoing operations and for internal planning and forecasting purposes. We believe these non-GAAP financial measures, when reviewed collectively with our GAAP financial information, provide useful supplemental information to investors in assessing our operating performance. These non-GAAP financial measures should not be considered as an alternative to GAAP financial information or as an indication of operating performance or any other measure of performance derived in accordance with GAAP, and may not provide information that is directly comparable to that provided by other companies in its industry, as these other companies may calculate non-GAAP financial measures differently, particularly related to non-recurring, unusual items. Management uses adjusted gross margin to measure profitability and the ability to scale and leverage the costs of Delivery Systems and Consumables. The continued growth of Delivery Systems is expected improve adjusted gross margin, as additional Delivery Systems sold will increase our recurring Consumables net sales, which has higher margins. Management believes adjusted gross profit and adjusted gross margin are useful measures to the Company and its investors to assist in evaluating operating performance because they provide consistency and direct comparability with past financial performance and between fiscal periods, as the metrics eliminate the effects of amortization and depreciation, which are non-cash expenses that may fluctuate for reasons unrelated to overall continuing operating performance. Adjusted gross margin has been and will continue to be impacted by a variety of factors, including the product mix, geographic mix, direct vs. indirect mix, the average selling price on Delivery Systems, and new product launches. Management expects adjusted gross margin to fluctuate over time depending on the factors described above. Management uses adjusted EBITDA and adjusted EBITDA margin to facilitate internal comparisons of historical operating performance on a more consistent basis and uses these measures for business planning purposes. Management also believes this information will be useful for investors to facilitate comparisons of operating performance and better identify trends in the business. Management expects adjusted EBITDA margin to increase over the long-term, as the Company continues to scale and achieve greater operating leverage. The Company calculates adjusted EBITDA as net income (loss) adjusted to exclude: change in fair value of public and private placement warrants, change in fair value of earn-out shares liability, other expense, net; interest expense; income tax benefit (expense); depreciation and amortization expense; stock-based compensation expense; foreign currency (gain) loss; management fees incurred from historical private equity owners; one-time or non-recurring items such as transaction costs (including transactions costs with respect to the Business Combination); and restructuring costs (including those associated with COVID-19). 2#3ANDREW STANLEICK President and Chief Executive Officer LIYUAN WOO Chief Financial Officer ● Joined BeautyHealth in February 2022 • Former EVP Americas, Coty; CEO, Kylie Jenner Beauty ● Advised Kim Kardashian West on her KKW Beauty business President, COACH Europe and COACH Asia • Unilever and L'Oréal sales and marketing roles (UK, France, Russia, Eastern Europe, SE Asia) ● ABOUT THE PRESENTERS ● Joined BeautyHealth in September 2020 • Former COO and CFO of The VOID, a virtual reality entertainment company ● COTY KYLIE COSMETICS KKW BEAUTY COACH L'ORÉAL NEW YORK Served as CFO for SharkNinja, Gymboree, and bebe Deloitte M&A and Financial Advisory Services B ● bebe Shark NINJA 3 GYMBOREE Unilever Deloitte.#4We are a category creator. We are an omnichannel beauty, health, and wellness platform. We are a connected community for those seeking to live their best lives. We are reinventing the consumer's relationship with their skin and self-confidence. BEAUTYHEALTH™ We are 8#5MEDICAL AESTHETICS Corrective and more invasive Injectables, energy-based devices, and treatments in a clinical setting DEFINING THE BEAUTY HEALTH INDUSTRY TRADITONAL BEAUTY Widely accessible, over-the-counter Topicals, supplements, digital tools BEAUTY HEALTH SKIN HEALTH WE ARE AN AND COMPANY, NOT AN OR COMPANY EXPANDING DEMOGRAPHICS Consumers seek approachable and effective solutions that bridge the gap between non-invasive and invasive options Consumers are more diverse across genders and are increasingly younger, offering a significant market opportunity NON- INVASIVE 95% of HydraFacial customers use other treatments in a year Medical Light Basic grade therapy facial skincare GENERATIONS Over 30% of customers at beauty retailers (Ulta, Sephora, etc.) are under 24 Source: Third party research 2019 reflecting pre-COVID conditions; United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019, Online Edition. Rev. 1 5 ■ Micro Micro- Chemical Lasers Injectables Non- Plastic derma- needling peels brasion surgical surgery face lifts GENDERS Providers predict ~2x growth in male mix of total facial patients INVASIVE GEOGRAPHIES ~70% of global population resides in Asia & Europe, representing substantial growth opportunity#6BEAUTY HEALTH SPANS MASSIVE GLOBAL OPPORTUNITIES... Wellness ~$1,500B 5-10% growth Personal Care & Beauty ~$955B 8% growth Skincare ~$155B 5% growth Haircare ~$95B 3% growth Spa Services ~$47.5B ~12% growth Source: McKinsey & Company for 2021 estimated wellness market size and growth; Global Wellness Institute for 2020 estimated personal care & beauty market size and growth; Statista for 2021 estimated market size for skincare and haircare and growth; Grand View Research for 2020 estimated spa market size and growth; Vantage Market Research for 2022 estimated market size and growth Aesthetics ~$12B ~11% growth#7...WITH NO SHORTAGE OF POTENTIAL CHANNELS Dermatologists Medical 1M-0 HAY PER Medical Spas Plastic and Aesthetic Surgeons Beauty Retail Hotels Resorts Non-Medical Experiential Retail Non-medical Spas Gyms / Studios Travel Retail#8face life faces first IT'S GLOW TIME CREATING THE CATEGORY WITH OUR FLAGSHIP BRAND hydrafacialⓇ BEAUTYHEALTH™ Source: Third party research 2019 reflecting pre-COVID conditions Cleanse. Extract. Hydrate. A highly effective, non-invasive and approachable experience. Appropriate for all ages, genders, skin tones, and skin types. Omnichannel distribution where consumers live, work, and play. 3 steps. 30 minutes. Best skin of your life. $200 Average cost to consumer ~5 month Average Delivery System payback period 40 NPS among consumers Higher than Botox Millions Experiences provided per year#93 Provider delivers HydraFacial experience to consumer ■ 2 Consumables purchased by provider BRIGHTEN ACTIV-4 BETA-HD 1 Delivery System sold to provider THE HYDRAFACIAL ECONOMIC MODEL ANTIOX-F I First-time buyers Existing providers buying additional Delivery Systems Existing providers upgrading older Delivery Systems 1 Provider purchases a Delivery System, empowering them to offer HydraFacial experiences to their consumers 2 Each HydraFacial experience requires the use of consumables (tips, solutions, serums) These consumables are sold exclusively by Beauty Health to our providers ■ 3 Provider markets HydraFacial experiences to their consumers. ■ ■ ■ BeautyHealth drives additional consumer awareness with marketing activation, pushing incremental demand to our providers Consumers re-visit for recurring HydraFacial experiences (our superconsumers visit 8x / year) Provider recognizes high ROI realized by offering HydraFacial experiences, leading to additional Delivery System purchases Glossary of Key Performance Indicators Delivery System ASP: Average sale price for a Delivery System Delivery Systems Sold: Number of Delivery Systems sold during a period Install Base: Total number of Delivery Systems actively employed by providers to offer experiences to consumers#10THE MASTER PLAN ∞ Expand our footprint by selling innovative products and connected experiences to providers and consumers. Invest in our providers, especially the trusted a/esthetician, turning them into brand evangelists and advocates providing first-class experiences Nurture direct relationships with our consumers, building brand awareness and driving them to our trusted community Build our global infrastructure and a connected technology platform to fuel growth and community engagement Supercharge our platform with targeted acquisitions to complement our portfolio and spin our flywheel faster 10#11Meet Syndeo. HydraFacial REIMAGINED LAUNCHED MARCH 2022 CONNECTED TECHNOLOGY EASE OF USE IMPROVEMENTS APP INTEGRATION HOME EXTENSION 11 BRANDY FACTS Yr Iwa zalow Opran MÁY#12OUR COMPETITIVE EDGE: THE CONNECTED COMMUNITY 20,399 80 Delivery System Install Base NPS among a/estheticians Become a top educator and deployer of beauty health professionals, empowering providers with knowledge of our products, experiences, and industry to propel careers ▪ Host education workshops and events at HydraFacial Experience Centers to generate loyalty and brand affinity THE BEAUTYHEALTH COMMUNITY A PROVIDERS 3 Steps. 30 Minutes. The Best Skin Of Your Life. Educate Source: Company information; third party research 2019 reflecting pre-COVID conditions; RealSelf.com (accessed 03/07/22) 8 Expand Activate PARTNERS Found where you live, work, and play. 12 98% "Worth It" Rating on RealSelf CONSUMERS You have to get it to get it. 40 NPS among consumers Higher than Botox Raise brand awareness and activate consumers to generate increased traffic to our provider network Engage with consumers - the average HydraFacial consumer receives multiple experiences per year#13Office & Assembly Facility, Long Beach, CA Flad LOVED AROUND THE WORLD... AND NEAR YOU hydrafacal London HFX Experience Center FACE LIFE FACE FIRS Glow Getter Shanghai HFX Experience Center AUTO WW That Glow Though! 13 90+ Countries and Territories Worldwide Direct Distributor HFX Experience Center 20,399 Delivery System Install Base#14☐ Develop international commercial organization to drive expansion and position as category creator ▪ Establish coverage in key cities in direct markets ▪ Focus on consumer through marketing strategy and programs to maximize awareness and demand Integrated social media: engage, amplify, aspire Estimated market opportunity by region¹ Asia Pacific 43% Nearly 2x North America opportunity North America 24% Statista estimates of global cosmetic market in 2020 as proxy; 2 RoW = Rest of World GOING GLOBAL Europe 22% ROW² 11% Beijing PAIN GAIN *** 闪耀而至 Shanghai Tokyo 14 BEAUTY IS A FEELING) *** 海菲秀 LIVE WORK PLAY ANO PAIN 等你来秀 ALL GAIN PARA Paris COTTON HIEFSpi Singapore London LON FLAGSHIP Glow#15ACQUISITIONS: ENHANCING THE FLYWHEEL MEDICAL AESTHETICS WELLNESS TRADTIONAL BEAUTY Acquisition criteria 1 Differentiated product or service / high Net Promoter Score 2 Complementary to our existing platform and community, leveraging the trusted a/esthetician 3 Financially attractive profile via compelling revenue growth, recurring revenue characteristics, or profitability 15#16Net sales by region ($mm) $166.6 13.8 28.4 122.4 2019 Net sales by segment ($mm) $166.6 85.2 81.4 Americas EMEA APAC 2019 $119.1 14.5 23.2 81.5 2020 Delivery Systems $119.1 65.7 53.4 2020 ■Consumables COMPELLING FINANCIAL PROFILE +118.3% YoY $260.1 43.7 47.0 169.4 2021 $260.1 120.6 139.5 2021 Non-GAAP measure; please refer to the appendix for a reconciliation to the appropriate GAAP measure Note: Totals may not sum and percentages may not recalculate due to rounding FY21 vs FY19 growth +56.2% +176.6% +65.2% +38.4% Gross margin 63.9% 2019 56.4% 2020 GAAP Gross Margin Net loss ($mm) 16 $1.6 2019 Adjusted EBITDA ($mm)¹ $36.7 22.0% 69.9% 2019 2021 6.5% $29.2 2020 -% margin $7.7 2020 70.7% 2019 65.5% +323.5% YoY 2020 Adjusted Gross Margin¹ $375.1 2021 $32.7 12.6% 74.0% 2021 2021 $901.9mm Cash and cash equivalents (12/31/21) $22,080 Delivery System ASP (2021) 6,191 Delivery Systems Sold (2021) 20,399 Install Base (2021)#17ANDREW STANLEICK President and Chief Executive Officer LED BY A VISIONARY MANAGEMENT TEAM B COTY KYLIE COSMETICS KKW BEAUTY L'ORÉAL COACH NEW YORK BEN BAUM Chief Experience Officer TORRID Google BCG O TARGET TAILORED BRANDS Unilever DAN WATSON EVP, Sales Americas stryker ORATECH Ethicon Endo-Surgery www or folmen-folion OF COMP BOSTON CONSULTING GROUP LIYUAN WOO Chief Financial Officer bebe Deloitte. GYMBORee Shark NINJA INDRA PAMAMULL President of APAC KENDO ONSEN JAPONICA DAVID JONES ESTEE LAUDER KELLIE SEARS Chief Human Resources Officer AskBio Allergan. Pfizer 17 JWALA KARNIK, MD EVP, Global Strategy & Partnerships SUNEVA iovera MEDICAL VERSANT McKinsey & Company ventures STEPHAN BECKER President of EMEA као со ТУ P&G Beiersdorf PAUL BOKOTA VP & General Counsel Spectrum TOSHIBA Brands JamesHardie#18KEY INVESTMENT HIGHLIGHTS 1 Category creating products and experiences 2) Consumer and provider loyalty ♡ BEAUTYHEALTH™ 3) Engaging and connected platform 4) Multi-dimensional growth opportunities 5) Compelling economic profile Differentiated technology 7 Experienced management and board 18#19drafacial hydrafacial BEAUTY IS A FEELING Wifi Las Gint LOVED AROUND THE WORLD AND NEAR YOU face life face first ESTIC APPENDIX#20Reconciliation of Gross Profit to Adjusted Gross Profit ($mm) Net sales Less: cost of sales Gross profit Gross margin RECONCILIATION OF NON-GAAP MEASURES Adjusted to exclude the following: Stock-based compensation expense Depreciation and amortization expense Adjusted gross profit Adjusted gross margin Year Ended December 31, 2020 $119.1 ($51.9) $67.2 56.4% 2021 $260.1 ($78.3) $181.8 69.9% 0.4 10.3 $192.5 74.0% 10.8 $78.0 65.5% 2019 $166.6 ($60.1) $106.5 63.9% 11.3 $117.8 70.7% Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDA Margin Year Ended December 31, 2020 $119.1 20 ($mm) Net sales Net income (loss) Adjusted to exclude the following: Change in fair value of warrant liability Change in fair value of earn-out shares liability Depreciation amortization expense Stock-based compensation expense Interest expense Income tax benefit Foreign currency loss, net Other expense (income) Management fees¹ Transaction related costs² Other non-recurring and one-time fees³ Adjusted EBITDA Adjusted EBITDA margin 2021 $260.1 (375.1) 277.3 47.1 17.8 12.4 11.8 (2.2) 0.1 4.5 0.2 34.9 4.0 $32.7 12.6% (29.2) 14.5 0.4 21.3 (9.3) 0.0 1.5 4.2 4.3 $7.7 6.5% 2019 $166.6 (1.6) 13.9 0.1 17.1 (1.3) (0.2) (0.5) 1.8 1.7 5.7 $36.7 22.0% ! Represents quarterly management fees paid to the former majority shareholder of the Company based on a pre-determined formula. Following the Business Combination, these fees are no longer paid. 2 For the year ended December 31, 2021, such amounts primarily represent direct costs incurred with the Business Combination, including $21.0 million paid to the former owner of HydraFacial, and to prepare HydraFacial to be marketed for sale by HydraFacial's shareholders in previous periods. 3 For year ended December 31, 2021, such costs primarily represent one-time retention awards related to the distributor acquisitions and executive recruiting and severance fees. For the year ended December 31, 2020, such costs primarily represent COVID-19 related restructuring cost of $3.2 million, including write-off of expired Consumables, discontinued product lines, human capital, cash management consultant fees, and, to a lesser extent, costs associated with a former warehouse and assembly facility during the transition period. For the year ended December 31, 2019, such costs include approximately $4.0 million related to the move from a former warehouse and assembly facility to a new warehouse and assembly facility, approximately $1.4 million to defend certain patents that were being infringed upon, and personnel costs associated with the restructuring of HydraFacial's salesforce, partially offset by a legal settlement received in favor of HydraFacial.#21♡ BEAUTYHEALTH WE ARE A CATEGORY CREATOR... DEMONSTRATING EXCITING GROWTH... USING A PROFITABLE & SCALABLE BUSINESS MODEL... TM IN A MARKET WITH HUGE GLOBAL OPPORTUNITY.